Family praise Rotherham United legends after hospice visit
Moore, had two spells as manager of Rotherham, winning two promotions, and also played for them more than 100 times.It was revealed recently he had been diagnosed with myeloma, an incurable form of blood cancer.Breckin, who is a an ambassador for the hospice, made more than 400 appearances for Rotherham between 1971 and 1983 and also had a short stint as manager.
Ms Ryalls said: "Within an hour or two [of contacting the club] the two legends were at my uncle's bedside. We were astounded by it. "We're ever, ever so grateful, especially given what Ronnie Moore is going through as well." She said the surprise visit had happened so quickly she had been unable to attend but said Mr Ryall's son, Matt, had told her it had "made his dad's life complete".The club said Millers "really do look out for one another"."It is our strong belief that we have a responsibility to repay supporters like Wayne when the opportunities present themselves and we hope that this small gesture went some way to doing that," a spokesperson for the side said.
Listen to highlights from South Yorkshire on BBC Sounds, catch up with the latest episode of Look North
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
10 minutes ago
- BBC News
Sesko signing 'definition of high risk, high reward'
And so another blossoming young forward from across the continent lands at Old Trafford, immediately shouldered by the burden of Manchester a starlet has fancied their chances across the past decade of despair. All have failed. Memphis Depay, Jadon Sancho, Antony and Rasmus Hojlund have come and (almost) is Benjamin Sesko's turn now. Another eye-watering transfer fee worth £74million only intensifies the pressure, especially coming off United's worst-ever Premier League there is reason for optimism that this time, finally, it will be is entering a superior environment than immediate predecessor Hojlund. He follows Matheus Cunha and Bryan Mbeumo through the door, two Premier League-proven attackers who should be relatively Fernandes and Amad Diallo are also creators, while Patrick Dorgu looks primed for a breakout campaign. Sesko should receive service from all angles, and he has already proven his ability to take chances in a variety of 6ft 5 frontman also should be the right profile. United emphasised their use of data in the announcement, pointing out that Sesko had scored more than every other player aged under 23 in Europe's top five leagues during the past two and athletically, he promises to meet the demands of the Premier League adequately. I think comparisons to Hojlund are justified (it's been a scarring year), but also 22, Sesko is two years older than the Dane when he arrived in 2023. He is also a much more established goalscorer, already netting 82 career goals across five seasons. Hojlund had 22 across is a risk and Ollie Watkins was Ruben Amorim's initially preferred option for a reason. His Premier League goal tally has never failed to reach double United's decision to go for the 'project striker' whose ceiling exceeds that of their alternative options is the definition of high risk, high more from Alex Turk at Turk Talks FC, external
Daily Mail
10 minutes ago
- Daily Mail
Sheffield Wednesday are 11/1 underdogs with Sky Bet to upset Leicester in the Championship today
After being relegated from the Premier League last season - Leicester's 2025-26 Championship campaign gets underway today. The Foxes' first game of the season will be against Sheffield Wednesday at King Power Stadium - a fixture the hosts enter as sizeable odds-on favourites at 2/9. Conversely, Sheffield Wednesday are 11/1 underdogs with Sky Bet, while a draw is priced at 5/1. In addition to the Full-time Result market - Sky Bet are offering four Price Boosts for this contest. The boosts require Jordan Ayew to win 3+ fouls at 6/5, Leicester to win by 4+ goals at 11/2, Stephy Mavididi to have 3+ shots on target at 7/1, and each team to have 5+ shots on target also at 7/1. Ayew won 53 fouls in the Premier League last season, while Mavididi recorded 20 goal contributions across all competitions when Leicester were last in the Championship in 2023-24. Additionally, Leicester and Sheffield Wednesday combined to have 23 total shots when these two sides last met. Sky Bet odds for Leicester vs Sheffield Wednesday: Leicester 2/9 Sheffield Wednesday 11/1 Draw 5/1 Sky Bet Price Boosts for Leicester vs Sheffield Wednesday: Jordan Ayew to win 3+ fouls WAS 1/1 NOW 6/5 Leicester to win by 4+ goals WAS 9/2 NOW 11/2 Stephy Mavididi to have 3+ shots on target WAS 6/1 NOW 7/1 Each team to have 5+ shots on target WAS 6/1 NOW 7/1
The Guardian
10 minutes ago
- The Guardian
Elderly people being excluded from medical research in UK, charities warn
People aged over 75 are being excluded from health research due to arbitrary age cut-offs, potentially stalling the development of life-saving treatments, leading charities and research institutes have warned. Some clinical studies restrict participation for older people due to concerns about the potential frailty of participants and a belief that age may reduce the effect of the drug or device being studied. Such restrictions are contributing to health inequity by excluding an important demographic from medical research, according to more than 40 charities and leading research funders, including the National Institute for Health and Care Research (NIHR), Cancer Research UK, the British Heart Foundation, and the Medical Research Council. Their joint statement warned that these age restrictions are unethical and lead to 'research not being representative of the groups who have [the] most disease'. The statement added: '[These restrictions] can result in treatments that are less effective for the very people who most need support … These exclusions are rarely justified and fail to align with the principles of equity and scientific excellence.' One example of this exclusion is dementia research, where only one in 10 people living with the disease are offered the opportunity to take part, with participation one of the biggest barriers to progress in this area, according to the Alzheimer's Society. Prof Chris Whitty, the chief medical officer, has warned that older adults are being 'frequently left out of research that directly affects their care', despite 'often having the highest levels of need'. 'This exclusion can lead to gaps in evidence, less effective treatments, and care that isn't properly tailored to those who use services the most. As the population ages, it's essential that research reflects the people it aims to serve,' he said. Some clinical studies have imposed age restrictions out of a misconception that older people with multiple morbidities could skew research results, while some studies are not designed in a way to accommodate older people, for example by requiring frequent visits to test centres that may be far away from where the participants live. The NIHR, which is the biggest health funder in the UK, said that the low proportion of older adults participating in research is both a scientific and ethical concern. Sign up to Headlines UK Get the day's headlines and highlights emailed direct to you every morning after newsletter promotion 'We should not assume that treatments that work in healthy, younger people will have the same effect in older adults,' said Prof Terry Quinn, the ageing lead at the NIHR. 'So excluding the predominant users of health and social care from research is at best inefficient, and at worst may produce misleading results.' The health minister Karin Smyth said: 'We know that older people are more likely to face long-term health conditions like cancer and dementia – yet recent data shows that only one in seven people taking part in vital medical research studies are over 75. 'If we want tomorrow's treatments to work for everyone today, older people must be part of the research that creates them. Through our 10-year health plan, we're turbocharging research and clinical trials – including by the NIHR launching a UK-wide recruitment drive for participants to get involved in research.'
